Brian Clevinger

Brian ClevingerBrian Clevinger, Ph.D. is managing director of Prolog Ventures, an early stage venture capital firm focusing on life science start-ups in the Missouri region.  Prolog has raised over $120M in three funds and has invested in over 35 health care companies, 16 of which were in St. Louis at the time of funding. Prior to Prolog, Dr. Clevinger was CEO of Megan Health, a vaccine company focused on food safety vaccines. He serves on the Board of the Center for Emerging Technologies, St. Louis Academy of Science, The Family Resource Center and a number of life science start-up companies. Dr. Clevinger holds a doctorate degree in immunology from Indiana University and was a post-doctoral fellow and tenured faculty member at Washington University, St. Louis, MO.